Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform

Go back to Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform
(NASDAQ: PSTV) Delayed: 3.83 +0.05 (1.32%)
Previous Close $3.78    52 Week High
Open $3.81    52 Week Low
Day High $4.00    P/E N/A 
Day Low $3.81    EPS
Volume 64,830